Maple Bridge Ventures invests in early‑stage, immigrant‑led technology companies across AgriFoodTech, HealthTech, and Enterprise Solutions. The firm backs globally ambitious founders whose perspectives, resilience, and global experience drive meaningful economic impact in Canada’s innovation economy. Maple Bridge invests at the pre‑seed and seed stages, writing initial cheques of $250,000 to $1 million.

Graphite Ventures is a trusted seed-stage venture capital firm investing in B2B software and hardware companies across Canada. The firm partners with founders at the early commercialization stage, providing hands-on support to help build capital-efficient businesses while preserving long-term strategic and financing optionality. With more than a decade of investing experience, Graphite actively supports over 100 Canadian B2B companies as they progress from early product-market fit to repeatable sales and scalable growth. Through its $120M Fund IV, Graphite makes initial seed investments of $500K to $1.5M in strong founding teams demonstrating early market traction.

Whitecap has been investing in Canadian companies for over 30 years and focus on early-stage (Seed and Series A) investments in Software and Healthcare companies.

CCRM Enterprises Inc., CCRM’s for-profit venture investment arm, creates value for regenerative medicine-based technologies and cell and gene therapy companies by making early stage investments while leveraging CCRM’s sector expertise and specialized infrastructure.

Forum Ventures® is the leading early-stage fund, accelerator and venture studio for B2B SaaS startups. Based in New York and Toronto, they’re on a mission to make the B2B SaaS journey easier, more accessible, and successful for early-stage founders. They invest in founders at the earliest stages and work with them to launch, build and scale their businesses. To date, they have made 500+ pre-seed and seed investments globally across industries like fintech, healthcare, applied AI, AI infrastructure, vertical AI, supply chain, and more.

REDDS Capital is a California based VC firm investing globally in early stage startups.

Esplanade HealthTech Ventures is Canada’s leading digital healthcare venture capital firm, investing in the US, Canada, Europe and Israel. Esplanade focuses on early-stage and high-growth companies shaping the future of healthcare delivery and actively empowering them to scale and grow. Esplanade has a strong focus on investment in women's health, including several investments in the menopause and osteoporosis space.

Renew Venture Capital is a US-based ventrue capital firm that produces excess returns for investors and changes inefficient, ineffective, and exclusionary systems for better outcomes. They invest exclusively on merit and in outcomes.

Amplitude Ventures is a capital catalyst for highly innovative companies at the point of value acceleration. They work with Canada's most promising healthcare companies that share their vision of bringing groundbreaking technologies to patients. Amplitude is focused on building world-class Canadian companies in precision medicine and next-generation medical devices. Since 2012, the Amplitude team has deployed a venture growth model used to build Canadian companies with world-class management teams and scale companies to breakout potential. This model has been used to create, build, and grow companies, resulting in over $1 billion in company value.